Table 2.
SNP ID | Gene | Model | Genotypes/minor allele | GDM | Controls | OR (95% CI) | P‐value | ||
---|---|---|---|---|---|---|---|---|---|
rs712699 | PAX4 | Additive | A/A vs G/G | 154 | 293 | 126 | 317 | 1.366 (1.021–1.828) | 0.036* |
rs1051295 | KCNB1 | Additive | C/C vs T/T | 149 | 247 | 125 | 316 | 1.579 (1.172–2.128) | 0.003* |
rs1042842 | MFN2 | Additive | A/A vs G/G | 153 | 278 | 135 | 358 | 1.398 (1.050–1.862) | 0.022* |
rs1050800 | LPIN1 | Additive | T/T vs C/C | 46 | 461 | 51 | 513 | 1.027 (0.665–1.587) | 0.903 |
rs1802295 | VPS26A | Additive | T/T vs C/C | 12 | 642 | 12 | 699 | 0.932 (0.411–2.113) | 0.866 |
rs10802502 | NLRP3 | Additive | C/C vs T/T | 195 | 228 | 201 | 221 | 0.945 (0.716–1.247) | 0.691 |
*Significant P‐values (P < 0.05). CI, confidence interval; GDM, gestational diabetes mellitus; OR, odds ratio; SNP, single‐nucleotide polyporphism.